Virax Biolabs logo

Virax Biolabs

VRAX | NASDAQ
Chart Builder DCF Calculator
$0.45
-$0.16 (-26.54%)
At close: Nov 16, 2026, 4:00 PM ET
$0.43
-$0.02 (-4.16%)
After-hours: Nov 16, 2026, 7:30 PM ET
-26.54%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
31
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #779/1021 (Top 76%)

Key Statistics

Market Data

Market Cap $602.56K
1D Range
0.43 0.51
52W Range
0.43 17.20

Valuation (TTM)

PE -0.02
PB 0.08
EV/EBITDA N/A

Valuation (NTM)

Forward PE N/A
Forward PEG 0.00
Price Target $1.00
Loading financial charts...

Profile

Virax Biolabs Group Limited is a biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. The company is developing T cell-based test technologies intende...

Sector Healthcare
Industry Biotechnology
Employees 26
IPO Date Jul 21, 2022
Fiscal Year April - March

Latest News

No news articles available yet.

Earnings

Next Earnings
Dec 2, 2026
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
1
Consensus
Buy
Price Target
$1.00
Upside
+122.22%
Buy (1)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.